Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-02-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULOUSE (31500), Haute-Garonne
PHARMACIE DE L'HERS : revenue, balance sheet and financial ratios
PHARMACIE DE L'HERS is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULOUSE (31500),
this company of category PME
shows in 2023 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'HERS (SIREN 502863343)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 492 923 €
2 681 580 €
2 292 134 €
2 054 942 €
1 930 475 €
1 724 873 €
1 737 695 €
N/C
Net income
100 766 €
121 355 €
196 497 €
113 788 €
90 774 €
68 246 €
116 884 €
129 467 €
117 677 €
EBITDA
N/C
162 842 €
276 606 €
171 902 €
152 571 €
121 652 €
171 452 €
190 060 €
N/C
Net margin
N/C
4.9%
7.3%
5.0%
4.4%
3.5%
6.8%
7.5%
N/C
Revenue and income statement
In 2024, PHARMACIE DE L'HERS generates positive net income of 101 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 118 k€ -> 101 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
100 766 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
22.122%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.727%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
92.473
84.023
77.665
81.399
78.258
56.596
43.142
31.335
22.122
Financial autonomy
46.618
48.284
48.381
47.581
47.55
53.12
59.685
64.445
68.727
Repayment capacity
None
5.025
5.749
7.124
5.879
4.589
2.391
2.984
None
Cash flow / Revenue
None%
7.486%
7.008%
4.844%
5.562%
5.234%
7.464%
4.932%
None%
Sector positioning
Debt ratio
22.122024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-6 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE L'HERS (22.12) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.73%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE L'HERS (68.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
2.98 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good+7 pts over 2 years
In 2023, the repayment capacity of PHARMACIE DE L'HERS (2.98) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 177.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
177.727
Liquidity indicators evolution PHARMACIE DE L'HERS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
271.887
237.097
210.151
149.752
171.168
169.707
210.983
193.714
177.727
Interest coverage
None
5.59
5.798
7.84
5.907
4.649
2.254
3.989
None
Sector positioning
Liquidity ratio
177.732024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average-6 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L'HERS (177.73) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
3.99x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good+12 pts over 2 years
In 2023, the interest coverage of PHARMACIE DE L'HERS (4.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L'HERS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
192 763 €
287 830 €
294 011 €
254 299 €
270 311 €
256 010 €
345 918 €
0 €
Inventory turnover (days)
0
32
43
48
43
40
35
46
0
Customer payment term (days)
0
4
6
6
5
6
4
8
0
Supplier payment term (days)
0
40
60
46
52
50
37
40
0
Positioning of PHARMACIE DE L'HERS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L'HERS is estimated at
1 406 767 €
(range 979 650€ - 2 104 605€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
979k€1406k€2104k€
1 406 767 €Range: 979 650€ - 2 104 605€
NAF 5 année 2024
Valuation method used
Net Income Multiple
100 766 €
×
14.0x
=1 406 768 €
Range: 979 651€ - 2 104 605€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'HERS with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'HERS
What is the revenue of PHARMACIE DE L'HERS ?
The revenue of PHARMACIE DE L'HERS in 2023 is 2.5 M€.
Is PHARMACIE DE L'HERS profitable?
Yes, PHARMACIE DE L'HERS generated a net profit of 101 k€ in 2024.
Where is the headquarters of PHARMACIE DE L'HERS ?
The headquarters of PHARMACIE DE L'HERS is located in TOULOUSE (31500), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE DE L'HERS ?
The tax return of PHARMACIE DE L'HERS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'HERS operate?
PHARMACIE DE L'HERS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart